Two Daily Disposable Contact Lenses in Symptomatic Patients

NCT ID: NCT03628599

Last Updated: 2019-07-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-13

Study Completion Date

2018-09-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the performance of DAILIES TOTAL1® and ACUVUE OASYS® 1-DAY and with respect to visual acuity in a symptomatic study population of monthly or bi-weekly replacement lens wearers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TOTAL1

Delefilcon A contact lenses worn bilaterally (in both eyes) for 4 weeks in a daily disposable modality

Group Type EXPERIMENTAL

Delefilcon A contact lenses

Intervention Type DEVICE

Water Gradient silicon hydrogel daily disposable contact lenses

1-DAY

Senofilcon A contact lenses worn bilaterally for 4 weeks in a daily disposable modality

Group Type ACTIVE_COMPARATOR

Senofilcon A contact lenses

Intervention Type DEVICE

Silicon hydrogel daily disposable contact lenses with HydraLuxe™ Technology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Delefilcon A contact lenses

Water Gradient silicon hydrogel daily disposable contact lenses

Intervention Type DEVICE

Senofilcon A contact lenses

Silicon hydrogel daily disposable contact lenses with HydraLuxe™ Technology

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DAILIES TOTAL1® (DT1) ACUVUE OASYS® 1-DAY

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to understand and must sign an IRB-approved informed consent form;
* Soft contact lens wearers in both eyes during the past 3 months;
* Best-corrected visual acuity (BCVA) 20/25 or better in each eye;
* Willing to wear study lenses at least 3 days per week and at least 8 hours per day;
* Willing to stop wearing habitual contact lenses for the duration of study participation.

Exclusion Criteria

* Infection, inflammation, abnormality, condition, disease, surgery, or use of medications, as specified in the protocol;
* Intolerance, hypersensitivity, or allergy to any component of the study products;
* Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
* Monocular (only one eye with functional vision).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alcon Research

Role: STUDY_DIRECTOR

Alcon Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alcon Investigative Site

Bloomington, Illinois, United States

Site Status

Alcon Investigative Site

Pittsburg, Kansas, United States

Site Status

Alcon Investigative Site

Powell, Ohio, United States

Site Status

Alcon Investigative Site

Warwick, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLS312-P001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.